Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 201

1.

[Pyoderma gangrenosum--a less well known ulcerous skin disease].

Kostiainen M, Snellman E, Vaalasti A, Rantanen T, Reunala T.

Duodecim. 2002;118(10):1033-7. Finnish. No abstract available.

PMID:
12237998
[PubMed - indexed for MEDLINE]
2.

[Infliximab for the management of pyoderma gangrenosum in inflammatory bowel disease: one for all?].

Tanczos BT, Baumgart DC.

Z Gastroenterol. 2006 Jul;44(7):609-10. German. No abstract available.

PMID:
16823703
[PubMed - indexed for MEDLINE]
3.

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.

Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR.

Am J Gastroenterol. 2003 Aug;98(8):1821-6.

PMID:
12907338
[PubMed - indexed for MEDLINE]
4.

Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases.

Cocco A, Angelucci E, Viscido A, Caprilli R.

Inflamm Bowel Dis. 2007 Oct;13(10):1317-9. No abstract available.

PMID:
17508417
[PubMed - indexed for MEDLINE]
5.

Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease.

Batres LA, Mamula P, Baldassano RN.

J Pediatr Gastroenterol Nutr. 2002 May;34(5):558-60. No abstract available.

PMID:
12050585
[PubMed - indexed for MEDLINE]
6.

[Infliximab for a girl with refractory pyoderma gangrenosum].

Nozawa T, Hara R, Kinoshita J, Sano F, Miyamae T, Imagawa T, Mori M, Hirokado M, Takahashi K, Inayama Y, Yokota S.

Nihon Rinsho Meneki Gakkai Kaishi. 2008 Dec;31(6):454-9. Japanese.

PMID:
19122376
[PubMed - indexed for MEDLINE]
Free Article
7.

Use of infliximab in pyoderma gangrenosum.

Hewitt D, Tait C.

Australas J Dermatol. 2007 May;48(2):95-8.

PMID:
17535196
[PubMed - indexed for MEDLINE]
8.

The simultaneous treatment of inflammatory bowel diseases and associated pyoderma gangrenosum with oral cyclosporin A.

Capella GL, Frigerio E, Fracchiolla C, Altomare G.

Scand J Gastroenterol. 1999 Feb;34(2):220-1. No abstract available.

PMID:
10192206
[PubMed - indexed for MEDLINE]
9.

Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab.

Swale VJ, Saha M, Kapur N, Hoffbrand AV, Rustin MH.

Clin Exp Dermatol. 2005 Mar;30(2):134-6.

PMID:
15725238
[PubMed - indexed for MEDLINE]
10.

Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.

López San Román A, Bermejo F, Aldanondo I, Carrera E, Boixeda D, Muñoz Zato E.

Rev Esp Enferm Dig. 2004 Jun;96(6):420-2; 422-4. English, Spanish.

PMID:
15230672
[PubMed - indexed for MEDLINE]
11.

Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.

Kouklakis G, Moschos J, Leontiadis GI, Kadis S, Mpoumponaris A, Molyvas E, Minopoulos GI.

Rom J Gastroenterol. 2005 Dec;14(4):401-3.

PMID:
16400359
[PubMed - indexed for MEDLINE]
Free Article
12.

Infliximab for peristomal pyoderma gangrenosum.

Mimouni D, Anhalt GJ, Kouba DJ, Nousari HC.

Br J Dermatol. 2003 Apr;148(4):813-6.

PMID:
12752145
[PubMed - indexed for MEDLINE]
13.

Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.

Juillerat P, Christen-Zäch S, Troillet FX, Gallot-Lavallée S, Pannizzon RG, Michetti P.

Dermatology. 2007;215(3):245-51. Review.

PMID:
17823524
[PubMed - indexed for MEDLINE]
14.

Peripheral regional aseptic neutrophilic lymphadenopathy associated with pyoderma gangrenosum.

Al-Niaimi F, Cox NH.

Br J Dermatol. 2009 Nov;161(5):1206-7. doi: 10.1111/j.1365-2133.2009.09426.x. Epub 2009 Aug 12. No abstract available.

PMID:
19678821
[PubMed - indexed for MEDLINE]
15.

Successful treatment of Pyoderma gangrenosum with potassium iodide.

Asahina A, Minatani Y, Tada Y, Mitsui H, Tamaki K.

Acta Derm Venereol. 2006;86(1):84-5. No abstract available.

PMID:
16586005
[PubMed - indexed for MEDLINE]
Free Article
16.

Idiopathic pyoderma gangrenosum: successful resolution with infliximab therapy and pro-inflammatory cytokines assessment.

Del Giacco SR, Firinu D, Lorrai MM, Serusi L, Meleddu R, Barca MP, Peralta M, Manconi PE.

Acta Derm Venereol. 2012 Jul;92(4):439-40. doi: 10.2340/00015555-1301. No abstract available.

PMID:
22392509
[PubMed - indexed for MEDLINE]
Free Article
17.

Pyoderma gangrenosum as initial manifestation of Graves' disease.

Livideanu C, Lipsker D, Paul C, Juillard J, Schubert B.

Clin Exp Dermatol. 2006 Sep;31(5):659-61.

PMID:
16780496
[PubMed - indexed for MEDLINE]
18.

[Infliximab treatment of peristomal pyoderma gangrenosum in ulcerative colitis].

Nybaek H, Jemec GB.

Ugeskr Laeger. 2005 Aug 8;167(32):2920-1. Danish. No abstract available.

PMID:
16109221
[PubMed - indexed for MEDLINE]
19.

Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab.

Ljung T, Staun M, Grove O, Fausa O, Vatn MH, Hellström PM.

Scand J Gastroenterol. 2002 Sep;37(9):1108-10.

PMID:
12374238
[PubMed - indexed for MEDLINE]
20.

Infliximab as a treatment for recalcitrant pyoderma gangrenosum.

Singh M, Andrew SM, Lear JT.

Clin Exp Dermatol. 2004 Mar;29(2):196-7. No abstract available.

PMID:
14987282
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk